定义并应用腺瘤检出率的本地相关基准
该研究提出使用目标人群数据定义腺瘤检出率(ADR)的本地基准,并以内镜医师ADR的95%置信区间上限是否包含基准来应用基准。在加拿大卡尔加里一区域筛查中心,2014年8492例结肠镜检查(平均ADR 29%),2015年5193例(平均ADR 32%);2015年最低可接受、标准诊疗和理想基准分别为25%、30%和39%。
要点
- ADR是经过最佳验证的结肠镜性能质量指标,ASGE/ACG结肠镜质量工作组设定的ADR基准为混合男女群体中≥25%。
- 该研究使用基线年内镜医师表现来制定并应用评估年基准,基准分为最低可接受、标准诊疗和理想三档。
- 应用基准时,判断内镜医师ADR的95%置信区间上限是否包含基准值。
核心结论
- 作者提出了在平均风险患者中定义和应用ADR基准的方法,这些基准超越了当前推荐的「最低可接受」阈值。
研究设计与样本
- 研究使用内镜医师基线年的表现来制定并应用评估年的基准,基准基于基线年ADR四分位数定义的绩效组的平均ADR。
- 研究在加拿大卡尔加里一区域筛查中心进行,纳入2014年8492例和2015年5193例结肠镜检查。
主要发现
- 2014年8492例结肠镜检查的平均ADR为29%,2015年5193例的平均ADR为32%。
- 2015年最低可接受、标准诊疗和理想基准分别为25%、30%和39%。
- 分别有1名(3%)、3名(10%)和12名(39%)内镜医师的ADR的95%置信区间未包含基准。
关键数值与推荐
- ASGE/ACG结肠镜质量工作组设定的ADR基准为混合男女群体中≥25%。
- 2015年评估年基准:最低可接受25%、标准诊疗30%、理想39%。
临床怎么用
- 作者提出可使用目标人群数据定义本地相关ADR基准,并应用内镜医师ADR的95%置信区间上限是否包含基准来评估。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The adenoma detection rate (ADR) is the best validated colonoscopy performance quality indicator. The ASGE/ACG Task Force on Colonoscopy Quality set an ADR benchmark of ≥25% in a mixed male/female population. We propose a novel means for defining locally relevant ADR benchmarks using data from the population of interest and for applying ADR benchmarks using 95% confidence intervals (CIs) of an endoscopist's ADR. We further propose that ADR benchmarks should be raised to reflect what can be achieved by high-performing endoscopists. METHODS: We used endoscopists' performance in a baseline year to develop and apply benchmarks in an assessment year. We defined assessment year benchmarks (Minimally Acceptable, Standard of Care, and Aspirational) based on the average ADR of performance groups defined by baseline year ADR quartiles. We demonstrated the use of these benchmarks in endoscopists performing screening colonoscopies by determining if the upper bound of the 95% CI of the endoscopist's ADR included the ADR benchmark. RESULTS: The study included 8,492 colonoscopies (mean ADR 29%) in 2014 and 5,193 colonoscopies (mean ADR 32%) in 2015, completed at a regional screening center in Calgary, Canada. The Minimally Acceptable, Standard of Care, and Aspirational benchmarks for 2015 were 25%, 30%, and 39%, respectively. The 95% CI of the ADR of 1 (3%), 3 (10%), and 12 (39%) endoscopists did not include the benchmark. DISCUSSION: We have proposed methods for defining and applying benchmarks for ADR in average-risk patients that go beyond the "minimally acceptable" threshold currently recommended.
引用
- Hilsden RJ, Rose SM, Dube C, et al. Defining and Applying Locally Relevant Benchmarks for the Adenoma Detection Rate. Am J Gastroenterol. 2019. PMID: 30848731. doi:10.14309/ajg.0000000000000120
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。